Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Said no one ever lmao.
Seriously though, at least in the short term, we good here, and my 335s filled for extras with a nice bounce off the bottom Bolli....soooo here's hoping :)
To us all!!!
Not only...... :) The most vocal back then though, and enough to get me looking harder and buy in. I bought a good part of that 3mm at .0088 :D
This is on the breakout boards list, but doesn't even make the Top 50 Read list yet lol.
Don't confuse their statement of 210,000 LED lights for 210,000 installations. I don't know the specific size of their street light, but let's say for example if 1 street lamp installation was 20 LEDs wide and 50 LEDs long, that's 1000 "lights" in one installation assembly.
210000/1000=210 installations,
210 installations * 3500 = 735,000 profit.
Still a significant number, but a far cry from the 735 million.
Here you go, it's not about us though. TDA sorts it out into PASO's ticker as news because it's filter algorithm sees "Patient Access Solutions"
Patient Access Solutions Market by Product & Service, Delivery Mode and End-user - Global Forecast to 2025 - ResearchAndMarkets.com
5:47 am ET January 21, 2021 (BusinessWire) Print
The "Patient Access Solutions Market by product & service (Training services, Eligibility Verification, Medical Necessity, Pre-certification), Delivery Mode (Web & Cloud, On premise), End-User (Providers, HCIT Outsourcing Companies) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The global patient access solutions market is projected to reach USD 2.4 billion by 2025 from USD 1.6 billion in 2020, at a CAGR of 8.5%.
Increasing patient volume and subsequent growth in the demand for health insurance, the growing importance of denials management, declining reimbursement rates, increase in the volume of unstructured data in the healthcare industry, and the rising need to curtail escalating healthcare costs are the major factors driving the growth of this market. However, high deployment costs are expected to restrain the growth of this market to a certain extent.
Services to have the largest share in Patient access solutions market
Based on product and service, the patient access solutions market is segmented into services and software. The services segment accounted for the largest share of the global patient access solutions market in 2019. The introduction of complex software and the need for system integration are expected to boost the services market in the coming years.
Support and Maintenance services to have the largest share in 2019
The patient access services market, by type, is segmented into support and maintenance, implementation, and training and education services. In 2019, the support and maintenance services segment accounted for the largest market share. Factors such as the increasing demand for upgradation and enhancements along with the increasing complexity of patient access software are driving the growth of the support and maintenance services segment.
Automated updating features to support the growth of web & cloud based solutions
Based on delivery mode, the patient access solutions market is segmented into web and cloud-based solutions and on-premise solutions. In 2019, the web and cloud-based solutions segment accounted for the largest share of the global patient access solutions market. The flexibility of working from remote areas, affordability, and automated updating features are some of the key advantages associated with web and cloud-based solutions.
North America dominated the Patient access solutions market in 2019
North America dominated the patient access solutions market in 2019, followed by Europe and the Asia Pacific. North America's large share in the global market is attributed to factors such as stringent regulations, increasing government support for improving healthcare infrastructure, the need for reducing healthcare costs, increasing volume of claims denials, high number of private healthcare payers and well-established government payers
Market Dynamics
Drivers
Need to Maintain Regulatory Compliance Increasing Patient Volume and Subsequent Growth in the Demand for Health Insurance Growing Importance of Denials Management Declining Reimbursement Rates Rising Need to Curtail Healthcare Costs
Restraints
Data Breaches and Loss of Confidentiality
Opportunities
Huge Growth Potential in Emerging Healthcare It Markets
Challenges
Dearth of Skilled It Professionals in the Healthcare Industry Reluctance to Adopt Patient Access Solutions
Companies Mentioned
3M Access One, Inc. Accureg Software Allscripts Healthcare Solutions, Inc. Cerner Corporation Cirius Group Cognizant Conifer Health Solutions Craneware Epic Systems Corporation Exela Technologies Experian plc Genentech, Usa Inc. (Roche) KyruUS Mckesson Corporation Optum Patient Access Solutions, Inc. SSI Group Vee Technologies Pvt. Ltd. Waystar
For more information about this report visit https://www.researchandmarkets.com/r/8yj8px
View source version on businesswire.com: https://www.businesswire.com/news/home/20210121005421/en/
SOURCE: Research and Markets
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Solid call on that #2 point, I had to look for myself.
https://www.amazon.com/Vitastem-Super-Healing-Antibiotic-Infections-associated/dp/B076V2RM46
CJ, BB, good to see you guys still know how to pick em. After almost 2 years and recovering from the shitstorm of life that follows after a divorce I'm back at a point to be able to play in the market again. All I had to do was hop back into here and see where you guys have been posting to know what I should be eyeing.
Been watching this all week while funds cleared and waiting for the re-trace. I was gonna pick up 40s but 30s are even better! Didn't expect the typical Friday sell-off to hit that hard but like everyone said, that's a full re-trace....and FWIW to those that care on the daily chart we should bounce right off that 200SMA sooooo today's drop even being ruthless at EOD, still signals a solid bottom!
Everything is an uncertain gamble until it isn't and we all know for sure ;)
Not always, but yes is a risk.
To perform a reverse merger into it, which allows them to take their company public without the expensive costs of an IPO. Yes there are still costs and delays to clean up the shell and do the R/M, but usually even then those are much less than the IPO route.
It happens fairly frequently, but is promoted all the time in the pinks, the trick is to find the ones that are genuine as they can be some huge money makers for a penny investor.
I have been all day....**note, not with shares owned prior to the change**
Fighting hard with that 200SMA line on the 1/2 hour chart.
Just crushed through the 200SMA on the 1/2 hour chart....if we can close above 8, that may become a good support as we go for the 50 on the daily at $8.32
GLTU as well. I'm no professional chart reader by any means, and again, we're kinda at the mercy of how the market will take the earnings report, but there are some at least strong signs that this may go to the upside.
A bullish MACD crossover about to happen on the daily chart as well as the histogram moving to the positive, price action is going in the right direction, volume is trending higher than it was during the last bull run, and we have an earnings catalyst right around the corner.......if it's well received by the market, we could be in for a fun ride.
50 period SMA on the 1/2 hour chart acting like some pretty strong resistance..
With a cash account you can sell a stock right after you buy....you just can't buy again with those funds until they settle per the T+3 rule.
Yep. Hoping for bounce city next week! This thing has been stuck in the .9-1.20 channel almost all year.
Because the Breakout Boards go by post counts.....not stock price
$1.96million traded here today....in a penny stock.... wheeeeeeeeee!
Just the investment value that they had in JUST publicly traded companies was $700million (as of Sept. 21st). Good to have that kind of cash backup!
and last Q's result doesn't include any of the income from MedReleaf....which would have increased to $33million. Unreal
Aurora-Branded retail stores as well with Al-Canna....man, the vertical integration here is awesome
Not gonna lie I'm a little jealous lol
9am Mountain, 8am Pacific ;)
Meh....remind them in 2 months and that they shouldn't have been so short sighted as to give you shit over one day's worth of action....
lol yup. I know it's apples/oranges, especially with the share structure, buuuuutttt I was trying to help emphasize Rocket's point about net loss being a common thing.
Ooooh, you ninja-edited lol.
.50 would be an amazing way to end 2018 :D!
Even a certain stock that just hit $300/share a couple days ago was even operating at a $12.8mm net loss over their last quarter lol.
You got it now!
Interesting wording that they used... I guess you could call it an "Initial public offering" on the new exchange, but in my mind if they're already publicly traded, that kinda negates the "initial" part.
I also believe that whole "travel ban" part was proved as false wasn't it?
Either way, the ACBFF ticker isn't a shell and is already directly linked to Aurora, but we haven't seen enough details yet to know what's exactly going to be put on the "real" exchange lol, whether they keep the ticker symbol or change it. Any ACBFF shares though should be transferred over once it happens.
Aurora is waaaayyyyy past the "IPO" stage and has been publicly traded for a few years now.
It's the Pink ticker that they've been using for initial access into the US market as their primary one is traded in Canada, however they're looking to get off of the pinks and onto one of the major US exchanges now, to broaden the investor scope and have access to institutional funding.
Touché, and a good point. At this point in the game I'm by no means impatient, nor frustrated, but just curious. I said back in April that I thought we were declining here due to an investor confidence aspect (because of the audit debacle) and I know some of that is inherent on playing in the Pinks anyways.....
For me I'm just giddy that I/we have shares in a company, that's literally doing millions of dollars a year in real revenue, with huge expansion plans that they're actively executing on.....and were able to buy them for sub-10 cents. My first ones were sub 3 cents, but those've been long gone into other's hands now......damn divorce's are rough I'll tell ya what.
There's tons of eyes on AMFE, if that article posted the other day is to be believed as true, AMFE "stock has also transformed to become one of the most traded stocks on the entire OTCBB", although that was short-lived.... so I was just putting some thoughts out there.
Thanks for the responses everybody.
Having been in this for going on 2 years now I'm still befuddled on exactly why we're still trading in this price range when the company is doing so well, bringing in actual high levels of revenue (now verified by the audit)
Is the board gaming industry just not as sexy? Is it because we're still technically listed as a cannabis stock, yet 90% of the PRs have nothing to do with cannabis (Gro3)? Lack of an IR firm getting our name out there in front of more folks than just the Twitter account? Our share structure is a little big sure, but honestly, is a $60mm USD market cap all we're worth? I don't believe so but the "market" seems to disagree.
Thoughts on any of these points from some of the fellow longs? Or hell, even the short-time positioners? I know I don't post here often anymore, especially after the last 6 months of round-robin audit talk, but I'm always here reading.....
Nevermind, I got the answer I was looking for :). This is going to be an exciting Q4 of this year!
Can I ask where you see that? Just would like to read it for myself. I see a lot about the deals in acquisitions closing in Q4 of this year, and the plan to raise funds with them through debt or equity financing....but haven't found any evidence of them planning on listing in the US.
Sounds like a game for us all to play at the shareholders meeting :)
Fair enough I guess.....just seems odd/frustrating at times. AbCann (now Vivo) has been doing things right for awhile now IMO, has a huge cash position, active facilities....and yet we were stuck in that 1-1.25 channel all summer. Now with the Canna Farms deal closing we broke out a little, but now finding another higher channel lol.